The interface between calmodulin (CaM) and the NO synthase (NOS) heme domain is the least characterized interprotein interface that the NOS isoforms must traverse through during catalysis. Our previous molecular dynamics simulations predicted a salt bridge between K497 in human inducible NOS (iNOS) heme domain and D118(CaM). Herein, the FMN -heme interdomain electron transfer (IET) rate was found to be notably decreased by charge-reversal mutation, while the IET in the iNOS K497D mutant is significantly restored by the CaM D118K mutation. The results of wild-type protein with added synthetic peptides further demonstrate the critical nature of K497 relative to the rest of the peptide sequence in modulating the IET. These data provide definitive evidence supporting the regulatory role of the isoform-specific K497 residue.
The nitric oxide synthases (NOSs) are a family of proteins catalyzing biosynthesis of nitric oxide NO from L-arginine with NADPH and O 2 as cosubstrates [1] . The NOS enzyme is exquisitely regulated in vivo by its partner, the Ca 2+ -sensing protein calmodulin (CaM). Each subunit of the NOS homodimer has two domains joined by a CaM-binding linker: a C-terminal electronsupplying reductase domain, which consists of (sub)domains with binding sites for NADPH (the electron source), FAD, and flavin mononucleotide (FMN), and an N-terminal heme-containing oxygenase domain. There are three NOS isoforms: endothelial, neuronal, and inducible NOS (eNOS, nNOS, and iNOS, respectively). The CaM-binding linker in iNOS binds CaM at a basal level of Ca 2+ , while in nNOS and eNOS, the CaM binding requires an increase in intracellular Ca 2+ concentration. Binding of CaM to NOS is thought to act as a 'molecular switch', which activates NO production by enabling electron flow from the flavin prosthetic groups to the heme. The CaM-controlled intersubunit FMN -heme interdomain electron transfer (IET) is essential in coupling electron transfer in the reductase domain with NO synthesis in the heme domain by delivery of electrons required for O 2 activation at the heme site [2, 3] . The NOS isoforms achieve their key biological functions by tight regulation of IET process via interdomain interactions. It is generally accepted that FMN domain motion plays a key role in the NOS activation by CaM [4, 5] : the FMN domain shuttles electrons by interacting alternatively with the FAD and heme domains [6] [7] [8] . The shuttling mechanism also operates in the ancestral electron transfer systems, while the novel aspect of the NOS enzyme is the involvement of Abbreviations CaM, calmodulin; eNOS, endothelial NOS; FMN hq , FMN hydroquinone; IET, interdomain electron transfer; iNOS, inducible NOS; k IET , rate constant for the FMN -heme IET; nNOS, neuronal NOS; NO, nitric oxide; NOS, NO synthase; oxyFMN, bidomain NOS construct in which only the heme-containing oxygenase and FMN domains along with the calmodulin CaM-binding region are present.
CaM. While the biochemical basis for CaM binding to NOS has become clearer [9, 10] , the molecular and dynamical details related to the interaction and assembly of NOS domains and CaM during catalysis are not completely understood [11, 12] .
Emerging evidence revealed that the CaM-heme (NOS) docking is required for formation of the FMNheme IET-competent conformation [10, 13] . The interprotein CaM/NOS interface is only beginning to be explored [10, 14] , and the interface between CaM and the NOS heme domain is the least characterized interdomain and interprotein interfaces that the NOS isoforms must traverse through during catalysis. Recent molecular dynamics (MD) simulations [15, 16] and pulsed EPR studies [17] [15] ; the IET states are defined in the direction of enzymatic turnover, and FMN hq stands for FMN hydroquinone. We predicted a salt bridge between K497 in the human iNOS heme domain and D118 of CaM at the heme-CaM docking interface that only forms in the post-IET state [15] (Fig. 1 ), but it was unclear whether such an interaction indeed affects the IET.
In the present work, we have experimentally examined role of this residue in the FMN -heme IET using an iNOS bidomain oxygenase/FMN (oxyFMN) construct. This construct only consists of the oxygenase and FMN domains connected by the CaM-binding linker, and represents a minimal electron transfer complex [18] . Using the oxyFMN construct has allowed researchers to obtain information specifically pertaining to the FMN/ heme/CaM domain docking complex [3, 10] . The experimental perturbation data herein have provided definitive evidence supporting the formation of a salt bridge between the isoform-specific K497 in the iNOS heme domain and D118 of CaM in the IET-competent conformation. This work also demonstrates the importance of experimentally studying the post-IET conformations.
Materials and methods

Expression and purification of human iNOS oxyFMN mutants
Constructions of the human iNOS oxyFMN and CaM mutant plasmids are described in Appendix S1 (see Table S1 for the primers). Purifications of the proteins were performed as previously described [19] . 
Laser flash photolysis
The experiments were performed on an Edinburgh LP920 laser flash photolysis spectrometer, in combination with a Q-switched Continuum Surelite I-10 Nd : YAG laser and Continuum Surelite OPO. A 446 nm laser pulse out of the OPO was focused onto the sample cuvette to trigger the FMN -heme IET reaction, which is an equilibrium process: FMNH˙+ Fe(II) ⇋ FMN hq + Fe(III). The IET kinetics is thus measured in both directions, and the CO photolysis approach follows the IET process in the reverse direction of the NOS enzymatic turnover [3] . The experiments were performed at 21°C [20] , and the details are described in Appendix S1. All the experiments were conducted at least twice. The transient absorbance changes were analyzed using ORIGINPRO 9.0 (OriginLab, Northampton, MA, USA).
CD spectroscopy
Room temperature CD spectra were recorded on a JASCO J-810 spectropolarimeter employing a Hamamatsu photomultiplier tube, using a 0.1-cm path-length quartz cell (Hellma USA Inc., Plainview, NY, USA). The instrument was calibrated using CSA, (1S)-(+)-Camphor-10-sulfonic acid, 1 mgÁmL À1 in a 1 mm cell [21] . Protein samples were diluted into phosphate buffer to 0.3 lM and filtered through a 0.2 lm filter. Spectra and buffer baselines were averaged from 16 scans, each recorded at 0.5 nm data pitch, using a scanning rate of 50 nmÁmin À1 and a response of 0.125 s. Subtracting the buffer baseline from samples yields the net CD spectra solely from the protein.
Results
The FMN -heme IET kinetics in the chargereversal and neutralization mutants
To determine if the K497 residue biases the FMNheme IET by electrostatic interaction, the kinetics in a K497E charge-reversal mutant of human iNOS oxyFMN construct were measured. The observed FMN -heme IET rate is 167 AE 8 s À1 (Fig. 2) , which is~48% smaller than that of the wild-type (wt) protein (321 AE 8 s
À1
); notable decreased IET rate was also observed for the K497D mutant (Table 1) . On the other hand, the rate of K497Q mutant decreased to a much less extent (Table 1) . These kinetic results of the iNOS K497 mutants showed that K497 regulates the FMN -heme IET via an ionic bond. We are aware that K497N mutant is more useful than K497Q as an analog to rat nNOS, which contains an Asn at this position (Fig. 1C) . However, the K497N mutation significantly altered protein expression, and we could not obtain sufficient amount of K497N iNOS mutant. Nonetheless, the similar charge-neutralization K497Q mutant should reasonably mimic the nNOS Asn residue at the equivalent site.
To further determine if the charge interacting partner of K497 is D118 in CaM (Fig. 1B) , we have measured the IET kinetics in the iNOS oxyFMN K497D mutant with bound CaM D118K mutant. This is to potentially restore a cross-domain charge interaction, but in reversed polarity. The observed IET rate in the iNOS oxyFMN K497D mutant is significantly restored by the charge-reversal at CaM D118 (from 192 AE 8 to 243 AE 9 s À1 ; see Table 1 ). A recent interesting kinetics study used similar polarity reversal strategy to examine role of cross-domain charge interactions in the FMNheme interface in a productive electron transfer complex in rat nNOS [22] . Our IET kinetics results for the iNOS K497 and CaM D118 mutants together provide direct evidence that the cross-protein charge pairing of K497 (iNOS) and D118 (CaM; Fig. 1A,B) is indeed involved in the FMN -heme electron transfer in human iNOS.
The FMN -heme IET kinetics of wt iNOS oxyFMN in the presence of synthetic peptides
We next determined the IET rates of wt oxyFMN protein with added synthetic peptide corresponding to the human iNOS K497 region (Tables S2). The iNOS-K497 peptide decreases the IET rate notably in a dose-saturable manner (Fig. 3) . Also note a similar inhibition of NO production activity of wt iNOS holoenzyme by the iNOS-K497 peptide (Table S5 and Fig. S2) . To further determine which portion/site of the iNOS-K497 peptide is most important for the observed inhibition of the IET and NO production activities, we measured the IET rate in the wt iNOS oxyFMN with added K497N mutant form of the iNOS peptide. Importantly, the inhibition of the FMN -heme IET by the iNOS-K497 peptide is eliminated by the K497N mutation (Table S3 and Fig. 3) , which attests the critical nature of K497 relative to the rest of the peptide sequence. This also demonstrates that the effect is guided mainly by the charged amino acids, but not the sequence. Moreover, the peptide corresponding to the equivalent site of rat nNOS (N712) does not affect the kinetics even at a [peptide] : [iNOS] ratio of 6 (Table S4 and Fig. 3) . These results for the synthetic peptides clearly demonstrated that it is the isoform-specific K497 residue that underlies the competition of the iNOS-K497 peptide with the corresponding endogenous sequence of the iNOS heme domain for specific binding to CaM, resulting in less proper CaM/NOS interactions. We are aware that the inhibitions of the IET and NO production activities by the iNOS-K497 peptide are not complete, indicating that the competition may not be very strong. It is worthy of note, though, that the purpose of using these peptides here is to probe the interacting interface so that other small organic compounds targeting this site could be screened in the future. We conclude from these kinetics data for the synthetic peptides that the isoform-specific CaM/heme(NOS) interface residue K497 is indeed involved in facilitating the FMN -heme IET.
Far-UV CD spectra of the iNOS oxyFMN mutants
To ensure that the mutated site does not disrupt the essential topological features at the protein surface, far-UV CD spectrum, a sensitive probe of protein secondary structure, has been obtained (Fig. 4) . Virtually identical spectra were obtained for 0.3 lM wt, K497D and K497E mutant iNOS proteins (with bound wt CaM). The well-defined spectra are characterized by minima at 208 and 222 nm, a maximum at 192 nm and baseline cross-over point at 200 nm. This is consistent with far-UV spectra of NOS proteins in the literature [23, 24] . Therefore, the K497D and K497E mutant proteins fold properly, and the mutations do not cause any significant structural perturbations, compared to the wt protein. 
Discussion
Our previous computational work demonstrated that the conformational change during the NOS IET is redox dependent [15] , and that the presumed ionic pair K497(NOS)ÁÁÁD118(CaM) only forms in the 'post-IET' conformation model where the redox states of Fe and FMN centers are Fe(II) and FMNH˙ (Fig. 1) (Fig. S1) ; the close contact between K497 and D118 (Fig. 1B) was not found in other iNOS docking models [10, 16] , either. Our experimental results herein validate the prediction of our MD simulations [15] on role of the isoform-specific K497 residue at CaM-heme (NOS) docking interface in the electron transfer process in NOS. This work thus demonstrates the importance of experimentally studying post-IET conformations. According to the principle of microscopic reversibility, the reaction pathway for the reverse reaction is the exact opposite of the pathway for the forward reaction. Therefore, the K497(NOS)ÁÁÁD118 (CaM) electrostatic interaction in the post-IET state [15] may be required to form a key intermediate state on the reverse pathway when the FMN domain comes nearer to the heme domain from a large number of free states. The formation of such an intermediate presumably reduces the arbitrariness of the FMN domain motions and biases the electron transfer process. The previous mass spectrometric and kinetics results provided useful insight into CaM docking to the heme domain [10] . Two CaM residues (Lys21 and Lys30) significantly affecting the kinetics do not make any obvious charge pairing contacts with the heme domain in their docking model [10] . This suggests that CaM undergoes dynamic structural adjustments, which bring these two CaM residues into a closer contact with the heme domain in other conformation(s). In other words, when CaM is near the NOS heme domain, it samples the heme domain surface and docks through distinct interfaces. It is thus important to not only experimentally measure the IET kinetics and define the docking interfaces but also inquiry the dynamics of the docked complex conformations using MD simulations [15] . The computations can also refine the conformations of the NOS docking models. Our work here thus clearly demonstrates that it is necessary to combine experimental kinetics measurements and computational simulations to study NOS proteins where the dynamic interactions between constituent domains or proteins determine the electron transfer mechanism. This work should also inspire further examination of the NOS FMN/heme/CaM docked complex models in both the pre-and post-IET oxidation states.
A previous study showed that a K423E rat nNOS mutant at the FMN-heme docking interface possesses 10-fold slower heme reduction [25] . The magnitude of this mutational effect is about 5-fold of that of the CaM-heme(NOS) site mutants studied here. This is not unexpected since the CaM-heme(NOS) interface area in the docked FMN/heme/CaM complex is significantly smaller than that of the FMN-heme interface [10] . It is also of note that murine iNOS mutants at the CaM-heme(NOS) interface (R80E and E279R) have similar or smaller detrimental effect on the IET kinetics [10] , compared to our human iNOS mutants at K497. These results indicate that the interdomain FMN/heme docking is primarily guided by electrostatic interactions between the charged surface residues in the FMN and heme domains, and the CaM-heme (NOS) docking plays an auxiliary but still notable role in bringing the docked FMN and heme domains to an IET-competent alignment. Another explanation is that CaM undergoes more extensive conformational sampling in the docked complex (see below).
The effects of the modification on the K497(NOS)-D118(CaM) pair are notable but not as dramatic as for other interactions between the FMN and CaM domains, pointing to a lesser role and/or significant conformational sampling in the docked complex with other conformations being also able to sustain electron transfer. For example, the human iNOS K497E mutation decreases electron transfer rate by 48% (Table 1) , while the same charge-reversal mutations of R536 [26, 27] or the equivalent residue R752 in nNOS [28] , a FMN domain residue engaged in a bridging interaction with CaM [9] , decrease the rates by 80-95%. Along the same lines, the polarity reversal in both proteins has only a moderate effect on the recovery of electron transfer rates [28] , although it is reassuring that the effect is in the expected direction. It is thus very possible that the conformational sampling in these NOS docked complexes is extensive, as observed in several studies of the different contact interfaces [10, 29, 30 ].
An understanding of conformational dynamics that is linked to NOS function may provide new opportunities for inhibitor design by targeting interfaces between the domain modules. The interdomain FMN/heme interacting surfaces are relatively well understood [25, [31] [32] [33] . The differences in the binding interfaces between isoforms may be subtle but there are noticeable differences in the polarity between eNOS/nNOS and iNOS [25] , with the iNOS FMN-heme domainbinding sites showing fewer surface charges. The FMN/heme docking site is thus a potential target to develop iNOS specific inhibitors. Equally important, the CaM-heme(NOS) docking is required for the FMN/heme domain alignment [10] . Importantly, our present work has demonstrated isoform-specific differences in the CaM/heme domain interface. The cross-protein interface is solvent exposed and could represent an attractive target for designing agents to selectively modulate the NOS isoform function (such agents remain scarce to date [34] ).
In conclusion, our kinetics data of discrete electron transfer and NO production have demonstrated that the CaM-heme(NOS) docking interface is isoform-specific and regulates the obligatory FMN -heme IET step in NOS function. Importantly, the experimental perturbation data have provided definitive evidence supporting the formation of a putative salt bridge between an isoform-specific K497 residue in the iNOS heme domain and D118 of CaM in the IET-competent conformation. The effects of the modification on the K497 (NOS)-D118(CaM) pair are notable but not as dramatic as for interactions at other CaM/NOS and FMN/heme interfaces, indicating significant conformational sampling in the docked complex with other conformations being also able to sustain electron transfer. This work should also inspire further experimental examination of the NOS FMN/heme/CaM docked complex models in both the pre-and post-IET oxidation states.
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